Brief: Alzchem Group Appoints Dr. Jürgen Sans As Chief Operating Officer With Effect From 1 January 2026
23/05/2025 08:03
May 23 (Reuters) - ALZCHEM GROUP AG ACT1.DE: SUCCESSFULLY COMPLETES LONG-TERM SUCCESSION PLANNING FOR ITS MANAGEMENT BOARD: SUPERVISORY BOARD APPOINTS DR. JÜRGEN SANS AS CHIEF OPERATING OFFICER WITH EFFECT FROM 1 JANUARY 2026 Source text: ID:nEQ22l5qza Further company coverage: ACT1.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on AlzChem AG
See all newsGermany's Alzchem jumps 6.5% after defence contractor CSG secures 20% stake
Brief: Alzchem Group AG Further Increase In Shareholding By Czechoslovak Group
Creamino Is Now Approved In EU For Use In Turkey Nutrition
Germany's Alzchem Group Q1 EBITDA, sales rise on specialty chemicals focus
Brief: Alzchem Confirms 2026 Forecast For Further Sales And EBITDA Growth